CytoSorbents Corporation, listed on NASDAQ as CTSO, is a New Jersey-based critical care company that focuses on blood purification for treating life-threatening conditions in the intensive care unit and cardiac surgery.
The company specializes in developing innovative technologies to improve patient outcomes and provide advanced solutions for critical care settings.
Generated from their website's infomation